Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 32 clinical trials
A Study Comparing MENOPUR in a Pen Formulation With a Powder and Solvent Formulation in Healthy Women

MENOPUR is a human menotrophin product, with a combination of human follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity. Human chorionic gonadotrophin (hCG) is the major

Accepts healthy volunteers
  • 0 views
  • 23 May, 2022
  • 1 location
Recombinant LH Prior to Ovarian Stimulation in Poor Ovarian Responders (PRE-LH)

described and oocyte donation is often offered as their only option to achieve pregnancy. Recently, evidence has emerged that supplementation with a specific hormone, luteinizing hormone (LH

antral
body mass index
antral follicle count
luteinizing hormone
ovarian stimulation
  • 0 views
  • 01 Sep, 2021
  • 3 locations
Role of Triptorelin 0.1 mg as a Luteal Phase Support in Assisted Reproductive Technique After Embryo Transfer : a Randomized Controlled Trial

(P) and estradiol (E2). The LP defect was primarily caused by reduced early-mid-luteal luteinizing hormone (LH) activity, resulting in a significant reduction in progesterone output by the corpora

Accepts healthy volunteers
  • 0 views
  • 27 May, 2022
  • 1 location
Prolonged Protocol of Early Follicular or Mid Luteal Phase

advantages in achieving ideal egg number, increasing endometrial receptivity to embryo transfer, inhibiting endogenous luteinizing hormone (LH) peak and reducing cycle cancellation rate. The full dose of

antral
embryo transfer
polycystic ovary syndrome
controlled ovarian hyperstimulation
ovarian hyperstimulation
  • 41 views
  • 24 Jan, 2021
  • 1 location
Pozzi Forceps in Intrauterine Insemination

Many infertility and subfertility issues are treated nowadays with intrauterine inseminations. This is a minimally invasive technique that consists in placing sperm into a woman's uterus. Inseminations have only a fair success rate despite advances in technology ( 7 % per cycle). The goal of this study is to find …

anovulatory
letrozole
Accepts healthy volunteers
secondary infertility
ovulation induction
  • 106 views
  • 25 Feb, 2022
  • 1 location
GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET

The objectives of this study are to compare the efficacy of the dual trigger group vs the hCG trigger group on the live birth rate in women undergoing IVF and the efficacy of the agonist in LP group vs the placebo group on the live birth rate in women undergoing …

gonadorelin
gonadotrophin releasing hormone analogue
  • 9 views
  • 27 May, 2022
  • 1 location
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome (CRM009)

The purpose of this study is to determine if estradiol augmentation of luteinizing hormone (LH) secretion secretion (primary endpoint) and follicle-stimulating hormone (FSH) secretion (secondary

testosterone
estradiol
Accepts healthy volunteers
hyperandrogenism
testosterone level
  • 251 views
  • 26 May, 2022
  • 1 location
Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?

hormone (LH) pulse frequency (primary endpoint) and overall LH and follicle-stimulating hormone secretion (secondary endpoints).

  • 8 views
  • 28 Jan, 2021
  • 1 location
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS (SHK001)

The objective of the study is to determine the relative contributions of four established predictors of hyperandrogenism (luteinizing hormone [LH] secretion, ovarian response to recombinant

testosterone
Accepts healthy volunteers
hyperandrogenism
testosterone level
hyperinsulinemia
  • 335 views
  • 28 Feb, 2022
  • 1 location
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism (CRM003)

The purpose of this study is two-fold. (1) We will determine if in mid- to late pubertal girls without hyperandrogenism (HA), progesterone (P4) acutely reduces waking luteinizing hormone (LH

Accepts healthy volunteers
  • 10 views
  • 26 May, 2022
  • 1 location